CC BY 4.0 · Rev Bras Ginecol Obstet 2022; 44(09): 838-844
DOI: 10.1055/s-0042-1751061
Original Article
Obstetrics

Placenta Accreta Spectrum Prenatal Diagnosis Performance: Are Ultrasound False-positive Results Acceptable in Limited-resources Settings?

Desempenho do diagnóstico pré-natal do espectro da placenta acreta: Os resultados falso-positivos do ultrassom são aceitáveis em ambientes com recursos limitados?
1   Clínica de Espectro de Acretismo Placentario, Fundación Valle del Lili, Cali, Colombia
,
1   Clínica de Espectro de Acretismo Placentario, Fundación Valle del Lili, Cali, Colombia
,
2   Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia
,
2   Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia
,
1   Clínica de Espectro de Acretismo Placentario, Fundación Valle del Lili, Cali, Colombia
,
1   Clínica de Espectro de Acretismo Placentario, Fundación Valle del Lili, Cali, Colombia
,
3   Departamento de Radiología, Fundación Valle del Lili, Cali, Colombia
,
3   Departamento de Radiología, Fundación Valle del Lili, Cali, Colombia
,
2   Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia
,
2   Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia
,
4   Facultad de Ciencias de la Salud, Programa de Medicina, Universidad Icesi, Cali, Colombia
,
5   Facultad de Ciencias de la Salud, Programa de Ginecología y Obstetricia, Universidad Icesi, Cali, Colombia
,
1   Clínica de Espectro de Acretismo Placentario, Fundación Valle del Lili, Cali, Colombia
› Author Affiliations

Abstract

Objective The immediate referral of patients with risk factors for placenta accreta spectrum (PAS) to specialized centers is recommended, thus favoring an early diagnosis and an interdisciplinary management. However, diagnostic errors are frequent, even in referral centers (RCs). We sought to evaluate the performance of the prenatal diagnosis for PAS in a Latin American hospital.

Methods A retrospective descriptive study including patients referred due to the suspicion of PAS was conducted. Data from the prenatal imaging studies were compared with the final diagnoses (intraoperative and/or histological).

Results A total of 162 patients were included in the present study. The median gestational age at the time of the first PAS suspicious ultrasound was 29 weeks, but patients arrived at the PAS RC at 34 weeks. The frequency of false-positive results at referring hospitals was 68.5%. Sixty-nine patients underwent surgery based on the suspicion of PAS at 35 weeks, and there was a 28.9% false-positive rate at the RC. In 93 patients, the diagnosis of PAS was ruled out at the RC, with a 2.1% false-negative frequency.

Conclusion The prenatal diagnosis of PAS is better at the RC. However, even in these centers, false-positive results are common; therefore, the intraoperative confirmation of the diagnosis of PAS is essential.

Resumo

Objetivo Recomenda-se o encaminhamento imediato de pacientes com fatores de risco para espectro placentário acreta (PAS, na sigla em inglês) para centros especializados, favorecendo assim o diagnóstico precoce e o manejo interdisciplinar. No entanto, erros diagnósticos são frequentes, mesmo em centros de referência (CRs). Buscou-se avaliar o desempenho do diagnóstico pré-natal para PAS em um hospital latino-americano.

Métodos Um estudo descritivo retrospectivo incluindo pacientes encaminhados por suspeita de SAP foi realizado. Os dados dos exames de imagem do pré-natal foram comparados com os diagnósticos finais (intraoperatórios e/ou histológicos).

Resultados Foram incluídos 162 pacientes no presente estudo. A idade gestacional mediana no momento da primeira ultrassonografia suspeita de PAS foi de 29 semanas, mas as pacientes chegaram ao CR de PAS com 34 semanas. A frequência de resultados falso-positivos nos hospitais de referência foi de 68,5%. Sessenta e nove pacientes foram operadas com base na suspeita de PAS com 35 semanas e houve 28,9% de falso-positivos no CR. Em 93 pacientes, o diagnóstico de PAS foi descartado no CR, com frequência de falso-negativos de 2,1%.

Conclusão O diagnóstico pré-natal de PAS é melhor no CR. Entretanto, mesmo nestes centros, resultados falso-positivos são comuns; portanto, a confirmação intraoperatória do diagnóstico de SAP é essencial.

Contributions

All authors contributed to the design of the study and were involved in the data collection, data analysis and/or interpretation. Also, all authors contributed to the writing/substantive editing and review of the manuscript and approved the final draft of the manuscript.




Publication History

Received: 06 January 2022

Accepted: 28 April 2022

Article published online:
06 September 2022

© 2022. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Hasegawa J, Tanaka H, Katsuragi S, Sekizawa A, Ishiwata I, Ikeda T. Maternal Death Exploratory Committee in Japan and the Japan Association of Obstetricians and Gynecologists. Maternal deaths in Japan due to abnormally invasive placenta. Int J Gynaecol Obstet 2018; 140 (03) 375-376
  • 2 Silver RM, Fox KA, Barton JR, Abuhamad AZ, Simhan H, Huls CK. et al. Center of excellence for placenta accreta. Am J Obstet Gynecol 2015; 212 (05) 561-568
  • 3 Shamshirsaz AA, Fox KA, Erfani H, Belfort MA. The role of centers of excellence with multidisciplinary teams in the management of abnormal invasive placenta. Clin Obstet Gynecol 2018; 61 (04) 841-850
  • 4 Nieto-Calvache AJ, Palacios-Jaraquemada JM, Hidalgo A, Vergara-Galliadi LLM, Charry RC, Daga LRA. et al. Management practices for placenta accreta spectrum patients: a Latin American hospital survey. J Matern Fetal Neonatal Med 2021; •••: 1-8
  • 5 Berkley EM, Abuhamad AZ. Prenatal diagnosis of placenta accreta: is sonography all we need?. J Ultrasound Med 2013; 32 (08) 1345-1350
  • 6 Bowman ZS, Eller AG, Kennedy AM, Richards DS, Winter III TC, Woodward PJ. et al. Accuracy of ultrasound for the prediction of placenta accreta. Am J Obstet Gynecol 2014; 211 (02) 177.e1-177.e7
  • 7 Dwyer BK, Belogolovkin V, Tran L. et al. Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging?. J Ultrasound Med 2008; 27 (09) 1275-1281
  • 8 Nieto AJ, Echavarría MP, Carvajal JA. et al. Placenta accreta: importance of a multidisciplinary approach in the Colombian hospital setting. J Matern Fetal Neonatal Med 2020; 33 (08) 1321-1329
  • 9 Collins SL, Ashcroft A, Braun T, Calda P, Langhoff-Ross J, Morel O. et al; European Working Group on Abnormally Invasive Placenta (EW-AIP). Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol 2016; 47 (03) 271-275
  • 10 Palacios Jaraquemada JM, Bruno CH. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet Gynecol Scand 2005; 84 (08) 716-724
  • 11 Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2019; 146 (01) 20-24
  • 12 Collins SL, Stevenson GN, Al-Khan A, Illsley NP, Impey L, Pappas L. et al. Three-dimensional power doppler ultrasonography for diagnosing abnormally invasive placenta and quantifying the risk. Obstet Gynecol 2015; 126 (03) 645-653
  • 13 Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol 2017; 217 (01) 27-36
  • 14 Nieto-Calvache AJ, Palacios-Jaraquemada JM, Osanan G, Cortes-Charry R, Aryananda RA, Bangal VB. et al; Latin American group for the study of placenta accreta spectrum. Lack of experience is a main cause of maternal death in placenta accreta spectrum patients. Acta Obstet Gynecol Scand 2021; 100 (08) 1445-1453
  • 15 Coutinho CM, Noel L, Giorgione V, Marçal LCA, Bhide A, Thilaganathan B. Placenta accreta spectrum disorders and cesarean scar pregnancy screening: are we asking the right questions?. Rev Bras Ginecol Obstet 2021; 43 (05) 347-350
  • 16 Calì G, Giambanco L, Puccio G, Forlani F. Morbidly adherent placenta: evaluation of ultrasound diagnostic criteria and differentiation of placenta accreta from percreta. Ultrasound Obstet Gynecol 2013; 41 (04) 406-412
  • 17 Mansour SM, Elkhyat WM. Placenta previa-accreta: do we need MR imaging. Egypt J Radiol Nucl Med 2011; 42 (3–4): 433-442
  • 18 Shih JC, Palacios Jaraquemada JM, Su YN, Shyu MK, Lin CH, Lin SY. et al. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol 2009; 33 (02) 193-203
  • 19 Finberg HJ, Williams JW. Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med 1992; 11 (07) 333-343
  • 20 Nieto-Calvache AJ, Vergara-Galliadi LM, Rodríguez F, Ordoñez CA, García AF, López MC. et al. A multidisciplinary approach and implementation of a specialized hemorrhage control team improves outcomes for placenta accreta spectrum. J Trauma Acute Care Surg 2021; 90 (05) 807-816
  • 21 Nieto-Calvache AJ, Palacios-Jaraquemada JM, Vergara-Galliadi LM, Nieto-Calvache AS, Zambrano MA, Burgos-Luna JM. Training facilitated by inter-institutional collaboration and telemedicine: an alternative for improving results in the placenta accreta spectrum. AJOG Glob Rep. 2021; 1 (04) 100028
  • 22 Morel O, van Beekhuizen HJ, Braun T, Collins S, Pateisky P, Calda P. et al; International Society for Placenta Accreta Spectrum (IS-PAS). Performance of antenatal imaging to predict placenta accreta spectrum degree of severity. Acta Obstet Gynecol Scand 2021; 100 (Suppl. 01) 21-28
  • 23 Nieto-Calvache AJ, Hidalgo-Cardona A, Lopez-Girón MC, Rodriguez F, Ordoñez C, Garcia AF. et al. Arterial thrombosis after REBOA use in placenta accreta spectrum: a case series. J Matern Fetal Neonatal Med 2020; •••: 1-4
  • 24 Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Belfort MA. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. Int J Gynaecol Obstet 2018; 140 (03) 281-290
  • 25 Nieto-Calvache AJ, López-Girón MC, Nieto-Calvache A, Messa-Bryon A, Benavides-Calvache JP, Burgos-Luna JM. A nationwide survey of centers with multidisciplinary teams for placenta accreta patient care in Colombia, observational study. J Matern Fetal Neonatal Med 2022; 35 (12) 2331-2337
  • 26 Wright JD, Silver RM, Bonanno C, Gaddipati S, Lu Y-S, Simpson LL. et al. Practice patterns and knowledge of obstetricians and gynecologists regarding placenta accreta. J Matern Fetal Neonatal Med 2013; 26 (16) 1602-1609